• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
Advertisement
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Rand Paul

    Tag: Rand Paul

    In this 2006 photo, Wal-Mart pharmacy technician Mark Pool fills a generic anti-inflammatory prescription at a Little Rock, Ark., Wal-Mart Super Center store. While the Constitution allows for patents, patents are temporary monopolies, meaning that drug companies want to extend their effective life as much as possible - much to the detriment of generics. (AP Photo/Mike Wintroath)
    Healthcare

    Congress can liberate drugs that come off their patents

    Peter Ferrara -
    December 26, 2017 5:01 am
    0
    Since becoming active on Twitter, Paul has celebrated Festivus by sharing his personal grievances in a series of good-humored tweets typically aimed at his congressional colleagues or government policies. (AP Photo/Andrew Harnik)
    News

    Rand Paul’s Festivus tweetstorm tackles UFOs, Ted Cruz, and Trump

    Katie Leach -
    December 23, 2017 6:55 pm
    0
    Sen. Rand Paul, R-Ky., tweeted:
    National Security

    Rand Paul: Obama administration against Trump might be ‘worse than Watergate’

    Anna Giaritelli -
    December 21, 2017 4:09 pm
    0
    Sens. Rand Paul, R-Ky., and Ron Wyden, D-Ore., gave a joint talk at George Washington University about the implication of mass surveillance and the eroding of the Fourth Amendment due to the War on Terror. (screenshot)
    Business

    The tech generation should reject mass surveillance

    Elias Atienza -
    December 20, 2017 11:54 pm
    0
    Sens. Rand Paul, R-Ky., (right) and Mike Lee, R-Utah, (left) said they would go that far to oppose a permanent authorization of Section 702 of the FISA law. (AP Photo/J. Scott Applewhite)
    Foreign Policy

    Rand Paul, Mike Lee will vote against spending bill with permanent FISA authorization

    Kelly Cohen -
    December 19, 2017 5:12 pm
    0
    News

    Surveillance law lapse would trigger legal fireworks in 2018

    Steven Nelson -
    December 17, 2017 5:01 am
    0
    Healthcare

    Lawmakers zero in on next target in fight against high drug prices

    Robert King -
    December 17, 2017 5:01 am
    0
    Industry groups try to deflect blame, while being chided by senators for the rising cost of prescription drugs. (AP Photo/Rich Pedroncelli)
    Healthcare

    Senators want to clamp down on drugmakers’ patent protections

    Robert King -
    December 12, 2017 8:33 pm
    0
    President Donald Trump speaks in the Diplomatic Reception Room of the White House, Wednesday, Nov. 15, 2017, in Washington, about his trip to Asia. (AP Photo/Pablo Martinez Monsivais)
    Immigration

    Trump insiders claim ‘unstoppable momentum’ despite media ‘derision’

    Paul Bedard -
    November 30, 2017 3:14 pm
    0
    Alex Azar, President Trump's HHS secretary nominee, served as the head of Eli Lilly's U.S. division from 2012 to 2017. During that time, the price of the Eli Lilly-made insulin drug Humalog rose from $122 for a vial in 2013 to $274 in 2017. (Graeme Jennings/Washington Examiner)
    Healthcare

    HHS nominee Alex Azar takes heat for raising insulin prices

    Robert King -
    November 29, 2017 6:21 pm
    0
    1...99100101...242Page 100 of 242
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.